Females demonstrated greater inability to regulate arousal as mood became more dysphoric.
2
This more severe form of PMS is called PMDD -premenstrual dysphoric disorder.
3
Conclusions: Premenstrual dysphoric disorder appears to be associated with serotonergic deficiency.
4
Finally, social support did not buffer the effect of life stress on dysphoric symptoms.
5
She later suffered from premenstrual dysphoric disorder, which causes mood swings, anger and depression.
6
In women with high dysphoric mood, elevated cortisol response was associated with low hypothalamo-hippocampal connectivity.
7
In those with worse dysphoric mood, elevated cortisol response predicted lower activity in hypothalamus and hippocampus.
8
Objective: Practice guidelines have advised against treating patients with antidepressants during bipolar mixed states or dysphoric manias.
9
In order to test the specificity of this stress buffering, we also examined it with regard to dysphoric mood.
10
Objective: Indirect evidence suggests that abnormalities in serotonergic function may be involved in the pathogenesis of premenstrual dysphoric disorder.
11
Overall, our findings demonstrated sex-dependent deficits in response to negative affective stimuli increasing as a function of dysphoric mood state.
12
Results: Compared to the normal subjects, the women with premenstrual dysphoric disorder had a significantly blunted prolactin response to fenfluramine.
13
The 25-year-old took to Instagram to reveal her struggle with premenstrual dysphoric disorder (PMDD) and body dysmorphia, reports Fox News.
14
The goal of this study was to test the hypothesis of serotonergic deficiency in premenstrual dysphoric disorder by measuring the prolactin response to fenfluramine.
15
Yaz is approved to treat a more serious condition known as premenstrual dysphoric disorder, or PMDD, which causes anxiety, tension, persistent anger and other symptoms.
16
The design of KOP analgesics devoid of hallucinatory and dysphoric effects has been hindered by an incomplete structural and mechanistic understanding of KOP agonist actions.